Related Experiment Video
Updated: Aug 7, 2026
Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
Published on: February 26, 2013
[Pulmonary vein orifice cryoablation for atrial fibrillation with mitral valve disease using a specially designed
Hiroshi Furukawa1, Toshio Konishi, Mutsumu Fukata
1Department of Cardiovascular Surgery, Yokohama Rosai Hospital, Yokohama. hmfurukawa@yahoo.co.jp
Objectives:
To evaluate the effectiveness of pulmonary vein orifice cryoablation (PVOC) for atrial fibrillation during mitral valve surgery.
Methods:
Twenty-two patients (12 men and 10 women) with mitral valve disease complicated with atrial fibrillation have been treated by PVOC since March 2000. During the mitral valve operations, all four pulmonary vein orifices were ablated using a ball-shaped cryo-probe. A newly designed cryo-probe was used for the last seven patients. Success was defined as atrial defibrillation within 6 months after the operation.
Results:
The success rate was 72.7% (16/22) of all patients, and improved from 66.6% to 85.7% (6/7) in the patients treated with the new cryo-probe. The mean left atrial dimension was smaller (50.2 +/- 4.1 vs. 61.5 +/- 9.4 mm, p < 0.01), and the duration of atrial fibrillation was also shorter (27.2 +/- 42.8 vs. 138.0 +/- 95.6 months, p < 0.01) in the successful group.
Conclusions:
PVOC with mitral valve surgery is a simple and less invasive procedure, so could be an effective option for atrial fibrillation.
More Related Videos
06:48Three-Dimensional Echocardiographic Method for the Visualization and Assessment of Specific Parameters of the Pulmonary Veins
Published on: October 28, 2020
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
